TrialCardiovascular diabetology2019

Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial.

Natia Peradze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.